Alpa Laboratories Q2 Results FY27 Preview: Results Date, Expectations and the Numbers That Will Decide the September 2026 Quarter

The Alpa Laboratories Q2 results FY27 announcement is the next scheduled earnings event for Alpa Laboratories Ltd., an Indore based pharmaceutical formulations maker producing generic, ethical and over-the-counter finished dosage forms for human and veterinary use, both under its own label and on contract. The stock traded at Rs 63.01 on the NSE on 9 September 2026, down 0.25% from the previous close of Rs 63.17, about 35.6% below its 52-week high of Rs 97.90 and 36.7% above its 52-week low of Rs 46.10.

What makes the Alpa Laboratories Q2 results print worth watching is the base it faces. The September 2025 quarter delivered Rs 26.26 crore of revenue and a profit of Rs 0.11 crore, while the most recent quarter on record, Q1 FY27, produced Rs 23.93 crore and a profit of Rs 0.98 crore. Everything below is built from those reported figures rather than from any forecast.

Click Here – Get Free Investment Predictions

When Is the Alpa Laboratories Q2 Results FY27 Date?

The Alpa Laboratories Q2 results date for FY27 is not confirmed. As of 9 September 2026, Alpa Laboratories Ltd. had not filed a board meeting intimation with the NSE or BSE for the September 2026 quarter, so any date circulating before that filing appears should be treated as unverified.

What can be stated is the regulatory boundary. Listed companies in India must publish quarterly results within 45 days of the end of the quarter, which places the outer deadline for the September 2026 quarter at 14 November 2026. Companies also have to give the exchanges prior intimation of the board meeting that approves the results, so the Alpa Laboratories Q2 results date becomes public through that filing rather than through any advance announcement.

The Alpa Laboratories Q2 results FY27 print covers 1 July 2026 to 30 September 2026. Small and mid-cap companies more often report in the second half of that window than in the first, so late October or early November is the range to watch for Alpa Laboratories.

Alpa Laboratories Q2 Results Expectations: What the Market Is Actually Tracking

No verified analyst estimate for the Alpa Laboratories Q2 results FY27 quarter is in the public domain, so no revenue or profit figure should be assumed for Alpa Laboratories. The Alpa Laboratories Q2 results watchlist below is built from what the company has actually reported and disclosed.

The first is whether the operating line returns to positive. Alpa Laboratories lost money at the operating level in both September 2025 and the June 2026 quarter, with margins of negative 8.57% and negative 16.55%, so the base itself was an operating loss.

The second is the gap between operating profit and reported profit. Every one of the last four quarters reported a net profit while three of them ran thin or negative operating margins, because non-operating income and a nil tax charge carried the result.

The third is that the June 2025 profit of Rs 11.77 crore came almost entirely from other income of Rs 11.94 crore on revenue of Rs 19.11 crore. That figure still sits inside the trailing earnings the current multiple is built on.

Check Alpa Laboratories Ltd. Live Fundamentals on the Univest Screener

Alpa Laboratories Q2 Results Preview: The Q1 FY27 Actuals It Builds On

Alpa Laboratories Ltd. reported revenue of Rs 23.93 crore in Q1 FY27, up 25.22% from Rs 19.11 crore in Q1 FY26, and a profit of Rs 0.98 crore at the net level, down 91.67% from Rs 11.77 crore in Q1 FY26. These are reported actuals, not estimates.

Sequentially, revenue was down 23.79% over the March 2026 quarter figure of Rs 31.40 crore, and net profit was down 28.99% from Rs 1.38 crore in Q4 FY26. Operating margin stood at negative 16.55% in Q1 FY27 against negative 8.57% in the September 2025 quarter, which is the comparison the Alpa Laboratories Q2 results print will be read against.

Q2 FY26 Base: The Comparison Alpa Laboratories Q2 Results FY27 Must Beat

Alpa Laboratories Ltd. reported revenue of Rs 26.26 crore and a profit of Rs 0.11 crore in Q2 FY26, the September 2025 quarter. That is the year-ago base against which the September 2026 numbers will be judged, and it is the single most useful figure in this Alpa Laboratories Q2 results preview.

Net profit in that base quarter was below the Rs 0.98 crore just reported for Q1 FY27, so the year-on-year comparison starts from a manageable level. Revenue of Rs 26.26 crore sits above the Rs 23.93 crore of the June 2026 quarter, which frames how much sequential movement the Alpa Laboratories Q2 results print needs to show growth.

Alpa Laboratories Quarterly Results Trend Over the Last Four Quarters

Quarter	Revenue (Rs Cr)	Net Profit (Rs Cr)
Q2 FY26 (Sep 2025)	26.26	0.11
Q3 FY26 (Dec 2025)	29.05	1.59
Q4 FY26 (Mar 2026)	31.40	1.38
Q1 FY27 (Jun 2026)	23.93	0.98

Figures in brackets denote negative numbers. All four quarters above are reported actuals taken from the company's exchange filings, and they are the only basis this Alpa Laboratories Q2 results preview uses.

Revenue across those four quarters ranged from Rs 23.93 crore to Rs 31.40 crore, and net profit from Rs 0.11 crore to Rs 1.59 crore. That spread is the honest context for the Alpa Laboratories Q2 results FY27 print, and it is why a single quarter should not be read as a trend on its own.

Key Factors That Could Shape Alpa Laboratories Q2 Results FY27

The Alpa Laboratories Q2 results outcome will turn on a small number of company-specific variables rather than on broad market conditions. The three below are the ones visible in what Alpa Laboratories has already reported.

Operating Loss Behind a Reported Profit

In the June 2026 quarter the company lost Rs 3.96 crore at the operating level and still reported a profit of Rs 0.98 crore. The reconciliation between those two lines is the first thing the September filing should be read for.

Capacity Use and Regulated Approvals

Formulations plants carry a largely fixed cost base, so utilisation decides margin more than price does. Approval status for regulated export markets is what determines which products can run through that capacity.

Trading Below Book Value

The stock trades at 0.71 times book value with essentially no borrowings, at a price-to-earnings ratio of 32.65 on earnings that have been largely non-operating. The balance sheet and the earnings tell different stories here.

Alpa Laboratories Q2 Results FY27: Share Price and Valuation Going Into the Print

Alpa Laboratories share price today is Rs 63.01 on the NSE, down Rs 0.16 or 0.25% from the previous close of Rs 63.17 on 9 September 2026, ahead of the Alpa Laboratories Q2 results announcement.

Metric	Value (9 September 2026)
NSE Symbol	ALPA
Current Market Price	Rs 63.01
52-Week High	Rs 97.90
52-Week Low	Rs 46.10
Market Capitalisation	Rs 132.97 crore
PE Ratio	32.65
PB Ratio	0.71
EPS (TTM)	Rs 1.93
Book Value per Share	Rs 88.50
Debt to Equity	0.02
Return on Equity	8.39%
50-Day Moving Average	Rs 65.94
200-Day Moving Average	Rs 68.72
RSI (14)	53.93

The stock trades below both its 50-day average of Rs 65.94 and its 200-day average of Rs 68.72, with a 14-day RSI of 53.93. None of this is a view on where the shares go once the Alpa Laboratories Q2 results are announced, and no price target is offered here.

Download the Univest iOS App or Univest Android App to track Alpa Laboratories Ltd. live price and quarterly earnings updates.

What Investors Should Watch When Alpa Laboratories Q2 Results Are Announced

Four lines carry most of the information in a company of this size, and reading them in order keeps the Alpa Laboratories Q2 results print in proportion.

1. Revenue against the Rs 26.26 crore reported in the September 2025 base quarter
2. Net profit against a profit of Rs 0.11 crore in that same quarter
3. Operating margin against negative 16.55% in Q1 FY27
4. Any exceptional item, provision or one-off gain disclosed alongside the numbers

A one-off gain or provision can move the reported profit far more than operations do in a company this size, which is why the Alpa Laboratories Q2 results announcement should be read together with the notes to the results rather than the headline alone.

Conclusion on Alpa Laboratories Q2 Results FY27

The Alpa Laboratories Q2 results date is not confirmed, and 14 November 2026 is the statutory outer limit rather than an expected date. Alpa Laboratories Ltd. will make the schedule public through a board meeting intimation to the exchanges, and until then the September 2026 quarter can only be framed by what has already been reported.

On that basis the Alpa Laboratories Q2 results FY27 print faces a base of Rs 26.26 crore in revenue and a profit of Rs 0.11 crore, with the most recent quarter having delivered Rs 23.93 crore and a profit of Rs 0.98 crore. No numerical estimate appears in this preview because no verified consensus figure exists for Alpa Laboratories, and readers should treat any preview that supplies one with caution. Verify every figure against the company filing on release and consult a SEBI-registered advisor before acting on quarterly earnings.

FAQs on Alpa Laboratories Q2 Results FY27

What is the Alpa Laboratories Q2 results date for FY27?

Ans. The Alpa Laboratories Q2 results date for FY27 is not confirmed. Alpa Laboratories Ltd. had not filed a board meeting intimation with the NSE or BSE as of 9 September 2026. Indian listing rules require the September 2026 quarter results to be published by 14 November 2026 at the latest.

What quarter do the Alpa Laboratories Q2 results 2026 cover?

Ans. The Alpa Laboratories Q2 results FY27 cover 1 July 2026 to 30 September 2026, known as the September 2026 quarter. Alpa Laboratories Ltd. reports revenue, operating profit and net profit for that period, and the Alpa Laboratories Q2 results filing also carries the notes to the accounts.

What were the Alpa Laboratories Q1 FY27 results?

Ans. Alpa Laboratories Ltd. reported revenue of Rs 23.93 crore in Q1 FY27 and a profit of Rs 0.98 crore at the net level. Revenue was up 25.22% versus Q1 FY26 and net profit was down 91.67% from Rs 11.77 crore in Q1 FY26.

What were Alpa Laboratories Q2 FY26 results in the September 2025 quarter?

Ans. Alpa Laboratories Ltd. reported revenue of Rs 26.26 crore and a profit of Rs 0.11 crore in Q2 FY26. Operating margin was negative 8.57%. Those figures form the base for the Alpa Laboratories Q2 results FY27 comparison.

What are the main Alpa Laboratories Q2 results expectations this quarter?

Ans. No verified analyst estimate is publicly available. The Alpa Laboratories Q2 results expectations centre on revenue against the Rs 26.26 crore base, net profit against a profit of Rs 0.11 crore, operating margin against negative 16.55% in Q1 FY27, and any exceptional item disclosed with the numbers.

What is Alpa Laboratories share price today ahead of the Q2 earnings?

Ans. Alpa Laboratories share price is Rs 63.01 on the NSE as of 9 September 2026, down 0.25% from Rs 63.17. The stock is about 35.6% below its 52-week high of Rs 97.90 and 36.7% above its 52-week low of Rs 46.10, at a market capitalisation of Rs 132.97 crore.

Is Alpa Laboratories a good stock to buy before the Q2 results?

Ans. This article does not offer a buy, sell or hold recommendation on Alpa Laboratories Ltd.. The stock trades at a price-to-book ratio of 0.71 with a return on equity of 8.39%. Assess the reported numbers when they are released and consult a SEBI-registered financial advisor before making any decision.